Amanda Vinson
About Amanda Vinson
Amanda Vinson is a Clinical Genomic Variant Scientist with a Ph.D. in Population Genetics from the University of Minnesota. She has extensive experience in genomic data analysis and has held positions at Novo Nordisk and Oregon Health & Science University before joining Variantyx in 2021.
Work at Variantyx
Amanda Vinson has been employed at Variantyx as a Clinical Genomic Variant Scientist since 2021. In this role, she applies her expertise in genomic data analysis to contribute to the understanding of genetic variants. Her responsibilities include developing computational approaches for genomic data interpretation and collaborating on research projects that advance the field of clinical genomics.
Previous Experience at Novo Nordisk
Prior to her current position, Amanda Vinson worked as a Consultant at Novo Nordisk from 2015 to 2016 for a duration of 11 months. During her time there, she contributed to projects that focused on genomic research, leveraging her background in population genetics and computational biology.
Education and Expertise
Amanda Vinson earned her Ph.D. in Population Genetics/Ecology, Evolution & Behavior from the University of Minnesota. Her academic background provides a strong foundation for her work in genomic variant analysis. She has developed novel computational approaches for analyzing genomic data, which enhances her contributions to research and clinical applications.
Background at Oregon Health & Science University
Amanda Vinson served as a Research Assistant Professor/Assistant Scientist at Oregon Health & Science University from 2008 to 2020, totaling 12 years of experience. In this position, she led various research projects, guiding them from the initial award phase through to publication. Her role involved significant engagement with both scientific and lay audiences, where she presented complex scientific data effectively.
Research and Presentation Skills
Amanda Vinson possesses extensive experience in presenting complex scientific data to diverse audiences, including both scientific communities and the general public. This skill is crucial for communicating research findings and promoting understanding of genomic science among various stakeholders.